High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains
Journal of Virology · 22.10.2024 · 98 (10)
DOI: 10.1128/jvi.00689-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 22.10.2024. Verfasst von Andrea N Loes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Antibodies, Neutralizing, Influenza A Virus, H1N1 Subtype, Influenza Vaccines. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The high genetic diversity of influenza viruses means that traditional serological assays have too low throughput to measure serum antibody neutralization titers against all relevant strains. To overcome this challenge, we developed a sequencing-based neutralization assay that simultaneously measures titers against many viral strains using small serum volumes using a workflow similar to traditional neutralization assays. The key innovation is to incorporate unique nucleotide barcodes into the hemagglutinin (HA) genomic segment, and then pool viruses with numerous different barcoded HA variants and quantify the infectivity of all of them simultaneously using next-generation sequencing. With this approach, a single researcher performed the equivalent of 2,880 traditional neutralization assays (80 serum samples against 36 viral strains) in approximately 1 month. We applied the sequencing-based assay to quantify the impact of influenza vaccination on neutralization titers against recent human H1N1 strains for individuals who had or had not also received a vaccine in the previous year. We found that the viral strain specificities of the neutralizing antibodies elicited by vaccination vary among individuals and that vaccination induced a smaller increase in titers for individuals who had also received a vaccine the previous year—although the titers 6 months after vaccination were similar in individuals with and without the previous-year vaccination. We also identified a subset of individuals with low titers to a subclade of recent H1N1 even after vaccination. We provide an experimental protocol ( dx.doi.org/10.17504/protocols.io.kqdg3xdmpg25/v1 ) and computational pipeline ( https://github.com/jbloomlab/seqneut-pipeline ) for the sequencing-based neutralization assays to facilitate the use of this method by others. IMPORTANCE We describe a new approach that can rapidly measure how the antibodies in human serum inhibit infection by many different influenza strains. This new approach is useful for understanding how viral evolution affects antibody immunity. We apply the approach to study the effect of repeated influenza vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Howard Hughes Medical Institute, Seattle, Washington, USA.
- Division of Basic Sciences, Computational Biology Program, and Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- HKU-Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
- World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
- Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA.
- Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Andrea N Loes, Jesse D Bloom
Förderung
- NCI NIH HHS
- NIH HHS
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Howard Hughes Medical Institute
- Research Grants Council, University Grants Committee
Zitieren
APA
Loes, A. N., Tarabi, R. A. L., Huddleston, J., Touyon, L., Wong, S. S., Cheng, S. M. S., Leung, N. H. L., Hannon, W. W., Bedford, T., Cobey, S., Cowling, B. J., & Bloom, J. D. (2024). High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains. Journal of Virology, 98(10). https://doi.org/10.1128/jvi.00689-24
Vancouver
Loes AN, Tarabi RAL, Huddleston J, Touyon L, Wong SS, Cheng SMS, et al. High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains. Journal of Virology. 2024;98(10). doi:10.1128/jvi.00689-24
BibTeX
@article{Loes2024,
author = {Loes, Andrea N and Tarabi, Rosario Araceli L and Huddleston, John and Touyon, Lisa and Wong, Sook San and Cheng, Samuel M S and Leung, Nancy H L and Hannon, William W and Bedford, Trevor and Cobey, Sarah and Cowling, Benjamin J and Bloom, Jesse D},
title = {High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains},
journal = {Journal of Virology},
year = {2024},
volume = {98},
number = {10},
doi = {10.1128/jvi.00689-24}
}
EUVIMED